Tracing leukemia stem cells and its influence on clinical course of adult acute myeloid leukemia
This study aimed to demonstrate the impact of LSCs on MRD induction day (14) and Day (28) on overall survival (OS) and disease free survival (DFS) as well as compare it to MRD status. 84 De novo adult AML patients tested for LSCs panels CD38/CD123/CD34/CD45, CD90/CD133/CD45/CD33 as well as different regular MRD panels.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Eman Z. Kandeel, Nahla El Sharkawy, Marwa Hanafi, Mohamed Samra, Azza M. Kamel Tags: Original Study Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Hematology | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Study